» Articles » PMID: 35658619

Donor Heterogeneity in the Human Macrophage Response to a Biomaterial Under Hyperglycemia

Overview
Date 2022 Jun 6
PMID 35658619
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages have a commanding role in scaffold-driven tissue regeneration. Depending on their polarization state, macrophages mediate the formation and remodeling of new tissue by secreting growth factors and cytokines. Therefore, successful outcomes of material-driven tissue vascular tissue engineering depend largely on the immuno-regenerative potential of the recipient. A large cohort of patients requiring vascular replacements suffers from systemic multifactorial diseases, such as diabetes, which gives rise to a hyperglycemic and aggressive oxidative inflammatory environment that is hypothesized to hamper a well-balanced regenerative process. Here, we aimed at fundamentally exploring the effects of hyperglycemia, as one of the hallmarks of diabetes, on the macrophage response to three-dimensional (3D) electrospun synthetic biomaterials for tissue engineering, in terms of inflammatory profile and tissue regenerative capacity. To simulate the early phases of the regenerative cascade, we used a bottom-up approach. Primary human macrophages ( = 8 donors) were seeded in two-dimensional (2D) culture wells and polarized to pro-inflammatory M1 and anti-inflammatory M2 phenotype in normoglycemic (5.5 mM glucose), hyperglycemic (25 mM), and osmotic control (OC) conditions (5.5 mM glucose, 19.5 mM mannitol). Unpolarized macrophages and (myo)fibroblasts were seeded in mono- or co-culture in a 3D electrospun resorbable polycaprolactone bisurea scaffold and exposed to normoglycemic, hyperglycemic, and OC conditions. The results showed that macrophage polarization by biochemical stimuli was effective under all glycemic conditions and that the polarization states dictated expression of the receptors (glucose transporter 1) and (fatty acid transporter). In 3D, the macrophage response to hyperglycemic conditions was strongly donor-dependent in terms of phenotype, cytokine secretion profile, and metabolic receptor expression. When co-cultured with (myo)fibroblasts, hyperglycemic conditions led to an increased expression of fibrogenic markers ( Together, these findings show that the hyperglycemic and hyperosmotic conditions may, indeed, influence the process of macrophage-driven tissue engineering, and that the extent of this is likely to be patient-specific. Impact Statement Success or failure of cell-free bioresorbable tissue-engineered vascular grafts hinges around the immuno-regenerative response of the recipient. Most patients requiring blood vessel replacements suffer from additional multifactorial diseases, such as diabetes, which may compromise their intrinsic regenerative potential. In this study, we used a bottom-up approach to study the effects of hyperglycemia, a hallmark of diabetes, on important phases in the regenerative cascade, such as macrophage polarization and macrophage-myofibroblast crosstalk. The results demonstrate a relatively large donor-to-donor variation, which stresses the importance of taking scaffold-independent patient-specific factors into account when studying biomaterial-driven tissue engineering.

Citing Articles

Personalized bone organoid using iPSC-derived cells for clinically relevant applications.

Gao Q, Teissier V, Zhu W, Makarcyzk M, Shinohara I, Murayama M Res Sq. 2024; .

PMID: 39711538 PMC: 11661298. DOI: 10.21203/rs.3.rs-5349885/v1.


Development of an iPSC-derived tissue-resident macrophage-based platform for the in vitro immunocompatibility assessment of human tissue engineered matrices.

Poulis N, Martin M, Hoerstrup S, Emmert M, Fioretta E Sci Rep. 2024; 14(1):12171.

PMID: 38806547 PMC: 11133401. DOI: 10.1038/s41598-024-62745-1.


Metabolic diversity of human macrophages: potential influence on intracellular survival.

Bertrand B, Shinde D, Thomas V, Whiteley M, Ibberson C, Kielian T Infect Immun. 2024; 92(2):e0047423.

PMID: 38179975 PMC: 10863412. DOI: 10.1128/iai.00474-23.